[Biological therapies in the treatment of anaemia associated with chronic kidney disease: a comparison of efficacy and safety of different erythropoiesis-stimulating agents]
Abdel–Kader Martín, L; Castillo Muñoz, MA; Ubago Pérez, R; Vega Coca, MD; Rodríguez López, R
Record ID 32013000639
Spanish
Authors' objectives:
To comparatively evaluate the efficacy and safety of the different available ESAs in adult and paediatric patients with anaemia associated with CKD.
Authors' recommendations:
In adult patients with anaemia associated with CKD, no significant differences were observed in efficacy between the four ESAs (erythropoietin α, erythropoietin, darbepoetin, and CERA) in terms of patients who reach target Hb levels, require PRBC transfusions, or changes in haemoglobin levels, or safety.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
https://www.aetsa.org/download/publicaciones/antiguas/AETSA_3_2013_TerBiol_IR_def.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Spain
MeSH Terms
- Anemia
- Erythropoietin
- Hematinics
Contact
Organisation Name:
Andalusian Health Technology Assessment Area
Contact Address:
Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name:
aetsa.csalud@juntadeandalucia.es
Contact Email:
aetsa.csalud@juntadeandalucia.es
Copyright:
Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.